4,865
Participants
Start Date
April 19, 2021
Primary Completion Date
October 8, 2021
Study Completion Date
October 8, 2021
Acceptability of OraQuick Advance© Rapid HIV-1/2 Antibody screening
Oral fluid-based HIV test
Bugiri Hospital, Bugiri
Nankoma HC IV, Bugiri
Kabuyanda HC IV, Kabuyanda
Rwekubo HC IV, Kahirimbi
Buremba HC III, Kazo
Kazo HC IV, Kazo
Butunduzi HC III, Kyenjojo
Kigarale HC III, Kyenjojo
Kasaali HC III, Kyotera
Barr HC III, Lira
Lira Regional Ref Hospital, Lira
Luwero HC IV, Kampala
St. Luke Namaliga HC III, Kampala
Kinoni HC III, Bukoto
Kiwangala HC III, Mbirizi
Kiyumba HC IV, Bukoto
Buwunga HC III, Masaka
Mbarara Regional Ref Hospital, Mbarara
Nyamityobora HC II, Mbarara
Kyantungo HC IV, Mityana
Mityana Hospital, Mityana
Mubende Kasambya HC III, Mubende
Nabingoola HC III, Nabingora
Mukono Cou HC IV, Mukono
Seeta-Nazigo HC III, Nakisunga
Kitwe HC IV, Kitwe
Ntungamo HC IV, Ntungamo
Lwamaggwa HC III, Rakai
Rakai Hospital, Rakai
Kajjansi HC III, Busiro
Kasangati HC IV, Kasangati
Mitukula HC III, Kyotera
Centers for Disease Control and Prevention
FED
Catholic Relief Services
OTHER